• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Incyte Corporation - Common Stock (NQ:INCY)

    101.42 +2.65 (+2.68%)
    Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,152,249
    Open 98.25
    Bid (Size) 101.05 (200)
    Ask (Size) 102.00 (100)
    Prev. Close 98.77
    Today's Range 97.94 - 101.50
    52wk Range 53.56 - 109.28
    Shares Outstanding 222,430,635
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    2 Safe-and-Steady Stocks Worth Your Attention and 1 Facing Challenges
    A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on higher-reward opportunities elsewhere. 
    Via StockStory
    News headline image
    Monday's session: top gainers and losers in the S&P500 index ↗
    Stay informed about the performance of the S&P500 index one hour before the close of the markets on Monday. Uncover the top gainers and losers in today's session for valuable insights. 
    Via Chartmill

    Performance

    YTD
    N/A
    N/A
    1 Month
    -0.0%
    -0.0%
    3 Month
    +17.5%
    +17.5%
    6 Month
    +48.2%
    +48.2%
    1 Year
    +45.9%
    +45.9%

    More News

    Read More
    News headline image
    Top S&P500 movers in Monday's session ↗
    Via Chartmill
    News headline image
    These S&P500 stocks are gapping in today's session ↗
    Via Chartmill
    News headline image
    Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma
    From Incyte
    Via Business Wire
    News headline image
    Incyte Japan Announces Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer
    From Incyte
    Via Business Wire
    News headline image
    Incyte to Present at Upcoming Investor Conference
    From Incyte
    Via Business Wire
    News headline image
    Incyte Announces European Commission Approval of Minjuvi® (tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma
    From Incyte
    Via Business Wire
    News headline image
    Incyte Announces Change to its Board of Directors
    From Incyte
    Via Business Wire
    News headline image
    Incyte Presents Updated Positive Data at ASH 2025 Reinforcing the Potential of INCA033989, its First-in-Class mutCALR-Targeted Monoclonal Antibody, in Patients with Essential Thrombocythemia
    From Incyte
    Via Business Wire
    News headline image
    Explore the top gainers and losers within the S&P500 index in today's session. ↗
    Via Chartmill
    News headline image
    These S&P500 stocks are gapping in today's session ↗
    Via Chartmill
    News headline image
    Incyte’s First-in-Class mutCALR-Targeted Monoclonal Antibody, INCA033989, Granted Breakthrough Therapy Designation by U.S. FDA
    From Incyte
    Via Business Wire
    News headline image
    Incyte Announces New Positive Data for INCA033989, its First-In-Class mutCALR-Targeted Monoclonal Antibody, in Patients with Myelofibrosis Presented at ASH 2025
    From Incyte
    Via Business Wire
    News headline image
    Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From Incyte Corporation
    Via Business Wire
    News headline image
    2 S&P 500 Stocks Worth Investigating and 1 We Brush Off
    Via StockStory
    Topics Stocks
    News headline image
    Incyte and Winnie Harlow Join Forces to Share Her Personal Vitiligo Story and Spark Conversation and Understanding
    From Incyte
    Via Business Wire
    News headline image
    Gapping S&P500 stocks in Monday's session ↗
    Via Chartmill
    News headline image
    Incyte Appoints Richard Hoffman as Executive Vice President and General Counsel
    From Incyte
    Via Business Wire
    News headline image
    Top S&P500 movers in Friday's session ↗
    Via Chartmill
    News headline image
    Gapping S&P500 stocks in Friday's session ↗
    Via Chartmill
    News headline image
    INCYTE CORP (NASDAQ:INCY) Fits Minervini Trend Template with Strong Growth Momentum ↗
    Via Chartmill
    News headline image
    2 Growth Stocks Set to Flourishand 1 Facing Challenges
    Via StockStory
    News headline image
    Integra LifeSciences, Evolent Health, Incyte, iRhythm, and Clover Health Stocks Trade Up, What You Need To Know
    Via StockStory
    Topics Economy
    News headline image
    Q3 Earnings Highs And Lows: Exact Sciences (NASDAQ:EXAS) Vs The Rest Of The Immuno-Oncology Stocks
    Via StockStory
    Topics Artificial Intelligence

    Frequently Asked Questions

    Is Incyte Corporation - Common Stock publicly traded?
    Yes, Incyte Corporation - Common Stock is publicly traded.
    What exchange does Incyte Corporation - Common Stock trade on?
    Incyte Corporation - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Incyte Corporation - Common Stock?
    The ticker symbol for Incyte Corporation - Common Stock is INCY on the Nasdaq Stock Market
    What is the current price of Incyte Corporation - Common Stock?
    The current price of Incyte Corporation - Common Stock is 101.42
    When was Incyte Corporation - Common Stock last traded?
    The last trade of Incyte Corporation - Common Stock was at 01/02/26 04:00 PM ET
    What is the market capitalization of Incyte Corporation - Common Stock?
    The market capitalization of Incyte Corporation - Common Stock is 22.56B
    How many shares of Incyte Corporation - Common Stock are outstanding?
    Incyte Corporation - Common Stock has 23B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.